A New Nail Genodermatosis: Familial Onychocytic Hamartoma Presenting as Polydactylous Longitudinal Leukonychia. Implications in the Early Detection of BAP1 Tumor Predisposition Syndrome

Onychocytic matricoma (OCM) is an acquired benign onychogenic tumor producing a localized thickening of the nail plate that usually presents as longitudinal pachymelanonychia. However, longitudinal pachyleukonychia as the presenting sign of OCM is increasingly recognized in clinical practice. To our knowledge, polydactylous OCM has not previously been reported in the literature. This study aims to describe a new nail genodermatosis presenting as polydactylous longitudinal leukonychia with histology typical of OCM. Four cases were identified. The previously unreported familial nail abnormality occurred in at least 2 first-degree relatives. Longitudinal white bands located exclusively on the fingernails were the only characteristic of this disease. The longitudinal bands varied in number from 2 to 4 per nail. Nail changes may appear during childhood, but most cases were observed between the ages of 20 and 50 years. The multiple longitudinal bands corresponded histologically to multiple OCM. Three cases in this series had no relevant personal of family history of neoplasm, but only 2 generations were analyzed. In 1 family, polydactylous OCM was associated with a family history of melanoma and renal cell carcinoma. The genomic profile of this single family allowed a diagnosis of OCM associated with BRCA1-associated protein ( BAP1 ) tumor predisposition syndrome (TPDS). Our results are limited by incomplete follow-up and the small size of this retrospective case series. As such tumors are rare, additional cases need to be collected to clarify the role of onychocytic hamartoma as an early indicator of BAP1 TPDS.

Authors

Institutions

Publication Details

Journal
American Journal of Dermatopathology
Published
2025-11-24
DOI
https://doi.org/10.1097/dad.0000000000003175
Primary Topic
Nail Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A New Nail Genodermatosis: Familial Onychocytic Hamartoma Presenting as Polydactylous Longitudinal Leukonychia. Implications in the Early Detection of BAP1 Tumor Predisposition Syndrome

Bérengère Dadone‐Montaudié, Christophe Perrin, François Petit
American Journal of Dermatopathology
Nail Diseases and Treatments
article

A New Nail Genodermatosis: Familial Onychocytic Hamartoma Presenting as Polydactylous Longitudinal Leukonychia. Implications in the Early Detection of BAP1 Tumor Predisposition Syndrome

Bérengère Dadone‐Montaudié, Christophe Perrin, François Petit
article en

Abstract

Onychocytic matricoma (OCM) is an acquired benign onychogenic tumor producing a localized thickening of the nail plate that usually presents as longitudinal pachymelanonychia. However, longitudinal pachyleukonychia as the presenting sign of OCM is increasingly recognized in clinical practice. To our knowledge, polydactylous OCM has not previously been reported in the literature. This study aims to describe a new nail genodermatosis presenting as polydactylous longitudinal leukonychia with histology typical of OCM. Four cases were identified. The previously unreported familial nail abnormality occurred in at least 2 first-degree relatives. Longitudinal white bands located exclusively on the fingernails were the only characteristic of this disease. The longitudinal bands varied in number from 2 to 4 per nail. Nail changes may appear during childhood, but most cases were observed between the ages of 20 and 50 years. The multiple longitudinal bands corresponded histologically to multiple OCM. Three cases in this series had no relevant personal of family history of neoplasm, but only 2 generations were analyzed. In 1 family, polydactylous OCM was associated with a family history of melanoma and renal cell carcinoma. The genomic profile of this single family allowed a diagnosis of OCM associated with BRCA1-associated protein ( BAP1 ) tumor predisposition syndrome (TPDS). Our results are limited by incomplete follow-up and the small size of this retrospective case series. As such tumors are rare, additional cases need to be collected to clarify the role of onychocytic hamartoma as an early indicator of BAP1 TPDS.

American Journal of DermatopathologyVol. 48(4)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Université Côte d'Azur (FR), Centre Hospitalier Universitaire de Nice (FR), Institut de Recherche sur le Cancer et le Vieillissement de Nice (FR), Centre Antoine Lacassagne (FR)
Openalex Percentile: Top 53%
Nail Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.